Covivio
GSEFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 25.1% | -4.6% | 10.5% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 76.6% | 81.1% | 83.9% | 82.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | -$0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $3 | $0 | $0 |
| Operating Expenses | $1 | $3 | $0 | $0 |
| Operating Income | $0 | -$2 | $1 | $1 |
| % Margin | 37.3% | -165.3% | 75.8% | 153.1% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | -$0 |
| Pre-Tax Income | $0 | -$2 | $1 | $1 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | $0 | -$1 | $1 | $1 |
| % Margin | 5.3% | -139.2% | 58.1% | 95.5% |
| EPS | 0.64 | -14.55 | 6.61 | 9.79 |
| % Growth | 104.4% | -320.1% | -32.5% | – |
| EPS Diluted | 0.64 | -14.55 | 6.57 | 9.73 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | $2 | $1 | $1 | $1 |
| % Margin | 133.1% | 95.4% | 82.1% | 79.3% |